• Je něco špatně v tomto záznamu ?

Evaluation of viscoelastic parameters and photo-based assessment of newly developed dermal substitutes modified with thermostabilized fibroblast growth factor 2

M. Knoz, J. Holoubek, B. Lipový, M. Faldyna, R. Chaloupková, V. Pavliňáková, J. Muchová, K. Kacvinská, J. Brtníková, J. Jarkovský, L. Vojtová

. 2024 ; 50 (6) : 1586-1596. [pub] 20240315

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013314

BACKGROUND: The purpose of dermal substitutes is to mimic the basic properties of the extracellular matrix of human skin. The application of dermal substitutes to the defect reduces the formation of hypertrophic scars and improves the scar quality. This study aims to develop an original dermal substitute enriched with stable fibroblast growth factor 2 (FGF2-STAB®) and test it in an animal model. METHODS: Dermal substitutes based on collagen/chitosan scaffolds or collagen/chitosan scaffolds with nanofibrous layer were prepared and enriched with FGF2-STAB® at concentrations of 0, 0.1, 1.0, and 10.0 μg ‧ cm-2. The performance of these dermal substitutes was tested in vivo on artificially formed skin defects in female swine. The outcomes were evaluated using cutometry at 3 and 6 months. In addition, visual appearance was assessed based on photos of the scars at 1-month, 3-month and 6-month follow-ups using Yeong scale and Visual Analog Scale. RESULTS: The dermal substitute was fully integrated into all defects and all wounds healed successfully. FGF2-STAB®-enriched matrices yielded better results in cutometry compared to scaffolds without FGF2. Visual evaluation at 1, 3, and 6 months follow-ups detected no significant differences among groups. The FGF2-STAB® effectiveness in improving the elasticity of scar tissues was confirmed in the swine model. This effect was independently observed in the scaffolds with nanofibres as well as in the scaffolds without nanofibres. CONCLUSION: The formation of scars with the best elasticity was exhibited by addition 1.0 μg ‧ cm-2of FGF2-STAB® into the scaffolds, although it had no significant effect on visual appearance at longer follow-ups. This study creates the basis for further translational studies of the developed product and its progression into the clinical phase of the research.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013314
003      
CZ-PrNML
005      
20240905133331.0
007      
ta
008      
240725s2024 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.burns.2024.03.020 $2 doi
035    __
$a (PubMed)38641499
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Knoz, Martin $u Department of Burns and Plastic Surgery, Institution Shared with the University Hospital Brno, Faculty of Medicine, Jihlavská 20, 625 00 Brno, Czech Republic; Clinic of plastic and esthetic surgery, St Anne's University Hospital, Pekarska 664/53, 602 00 Brno, Czech Republic
245    10
$a Evaluation of viscoelastic parameters and photo-based assessment of newly developed dermal substitutes modified with thermostabilized fibroblast growth factor 2 / $c M. Knoz, J. Holoubek, B. Lipový, M. Faldyna, R. Chaloupková, V. Pavliňáková, J. Muchová, K. Kacvinská, J. Brtníková, J. Jarkovský, L. Vojtová
520    9_
$a BACKGROUND: The purpose of dermal substitutes is to mimic the basic properties of the extracellular matrix of human skin. The application of dermal substitutes to the defect reduces the formation of hypertrophic scars and improves the scar quality. This study aims to develop an original dermal substitute enriched with stable fibroblast growth factor 2 (FGF2-STAB®) and test it in an animal model. METHODS: Dermal substitutes based on collagen/chitosan scaffolds or collagen/chitosan scaffolds with nanofibrous layer were prepared and enriched with FGF2-STAB® at concentrations of 0, 0.1, 1.0, and 10.0 μg ‧ cm-2. The performance of these dermal substitutes was tested in vivo on artificially formed skin defects in female swine. The outcomes were evaluated using cutometry at 3 and 6 months. In addition, visual appearance was assessed based on photos of the scars at 1-month, 3-month and 6-month follow-ups using Yeong scale and Visual Analog Scale. RESULTS: The dermal substitute was fully integrated into all defects and all wounds healed successfully. FGF2-STAB®-enriched matrices yielded better results in cutometry compared to scaffolds without FGF2. Visual evaluation at 1, 3, and 6 months follow-ups detected no significant differences among groups. The FGF2-STAB® effectiveness in improving the elasticity of scar tissues was confirmed in the swine model. This effect was independently observed in the scaffolds with nanofibres as well as in the scaffolds without nanofibres. CONCLUSION: The formation of scars with the best elasticity was exhibited by addition 1.0 μg ‧ cm-2of FGF2-STAB® into the scaffolds, although it had no significant effect on visual appearance at longer follow-ups. This study creates the basis for further translational studies of the developed product and its progression into the clinical phase of the research.
650    _2
$a zvířata $7 D000818
650    12
$a fibroblastový růstový faktor 2 $7 D016222
650    _2
$a prasata $7 D013552
650    _2
$a ženské pohlaví $7 D005260
650    12
$a umělá kůže $7 D017768
650    12
$a chitosan $7 D048271
650    12
$a pružnost $7 D004548
650    _2
$a tkáňové podpůrné struktury $7 D054457
650    _2
$a kolagen $7 D003094
650    _2
$a viskozita $7 D014783
650    _2
$a jizva hypertrofická $7 D017439
650    _2
$a popálení $7 D002056
650    _2
$a hojení ran $x účinky léků $7 D014945
650    _2
$a nanovlákna $x terapeutické užití $7 D057139
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a kůže $7 D012867
655    _2
$a časopisecké články $7 D016428
700    1_
$a Holoubek, Jakub $u Department of Burns and Plastic Surgery, Institution Shared with the University Hospital Brno, Faculty of Medicine, Jihlavská 20, 625 00 Brno, Czech Republic. Electronic address: holoubekjakub@yahoo.com
700    1_
$a Lipový, Břetislav $u Department of Burns and Plastic Surgery, Institution Shared with the University Hospital Brno, Faculty of Medicine, Jihlavská 20, 625 00 Brno, Czech Republic; CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic
700    1_
$a Faldyna, Martin $u Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic
700    1_
$a Chaloupková, Radka $u Enantis s.r.o., Kamenice 771/34, 625 00 Brno, Czech Republic
700    1_
$a Pavliňáková, Veronika $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic
700    1_
$a Muchová, Johana $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic
700    1_
$a Kacvinská, Katarína $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic
700    1_
$a Brtníková, Jana $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic
700    1_
$a Jarkovský, Jiří $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 735/5, 625 00 Brno, Czech Republic
700    1_
$a Vojtová, Lucy $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic
773    0_
$w MED00000977 $t Burns $x 1879-1409 $g Roč. 50, č. 6 (2024), s. 1586-1596
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38641499 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133325 $b ABA008
999    __
$a ok $b bmc $g 2143246 $s 1225180
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 50 $c 6 $d 1586-1596 $e 20240315 $i 1879-1409 $m Burns $n Burns $x MED00000977
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace